Merck & Co., Inc., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 12,955,016 shares at $16.00 ($65.9M) on 2019-04-08, disclosed to the SEC on 2019-04-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 8,833,333 | $0 | 0.0% |
| 2 | $16.00 | 4,121,683 | $65.9M | 100.0% |
| Total | $5.09 avg | 12,955,016 | $65.9M | 100% |
| Filing → |